Bausch Health Companies (BHC) Total Debt (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Total Debt came in at $20.8 billion in Q1 2026, down 3.47% year-on-year from $21.5 billion in Q1 2025, and little changed quarter-over-quarter from $20.8 billion in Q4 2025.
Bausch Health Companies (BHC) Total Debt (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Total Debt across 18 years of filings, most recently posting $20.8 billion for Q1 2026.
- Total Debt for Q1 2026 came in at $20.8 billion, down 3.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.8 billion (down 3.47% YoY), and the FY2025 annual result was $20.8 billion, down 3.7% from the prior year.
- Total Debt came in at $20.8 billion for Q1 2026 at Bausch Health Companies, roughly flat from $20.8 billion in the prior quarter.
- In the past five years, Total Debt ranged from a high of $23.2 billion in Q1 2022 to a low of $20.6 billion in Q2 2023.
- The 5-year median for Total Debt is $21.5 billion (2025), against an average of $21.5 billion.
- Peak annual rise in Total Debt reached 7.81% in 2023, while the deepest fall reached 10.86% in 2023.
- Bausch Health Companies' Total Debt stood at $20.8 billion in 2022, then grew by 7.81% to $22.4 billion in 2023, then retreated by 3.45% to $21.6 billion in 2024, then slipped by 3.7% to $20.8 billion in 2025, then declined by 0.25% to $20.8 billion in 2026.
- The last three Total Debt figures came in at $20.8 billion (Q1 2026), $20.8 billion (Q4 2025), and $21.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.63 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.53 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.99 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.51 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 570.41 Mn |
| 10 | Bausch Health Companies | 1.93 Bn | 1.59 Bn | 2.48 Bn | 20.76 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.76 Bn |
| Dec 31, 2025 | 20.82 Bn |
| Sep 30, 2025 | 21.04 Bn |
| Jun 30, 2025 | 21.74 Bn |
| Mar 31, 2025 | 21.51 Bn |
| Dec 31, 2024 | 21.62 Bn |
| Sep 30, 2024 | 21.51 Bn |
| Jun 30, 2024 | 21.66 Bn |
| Mar 31, 2024 | 22.07 Bn |
| Dec 31, 2023 | 22.39 Bn |
| Sep 30, 2023 | 22.43 Bn |
| Jun 30, 2023 | 20.55 Bn |
| Mar 31, 2023 | 20.65 Bn |
| Dec 31, 2022 | 20.77 Bn |
| Sep 30, 2022 | 21.22 Bn |
| Jun 30, 2022 | 21.81 Bn |
| Mar 31, 2022 | 23.17 Bn |
| Dec 31, 2021 | 22.65 Bn |
| Sep 30, 2021 | 22.36 Bn |
| Jun 30, 2021 | 23.44 Bn |